原著論文

  • Otsubo T, Shinzato K, Yamaguchi T*, Nakashima K, Takahashi Y, Tsuruta K, Edayoshi M, Shichida S, Osako R, Nishimura Y, Yokoi K, Fukui A, Hirota K, Takigawa M, Miyazaki K, Shintani-Domoto Y, Ito K, Aoki S, Kawaguchi A, Nomura S, Sasano T, Takahashi N, and Node. Feasibility and Safety of Atrial Biopsy ―Evidence From 1,000 Cases ― Circulation reports 2025. https://doi.org/10.1253/circrep.CR-25-0101

  • Shinzato K, Takahashi Y, Yamaguchi T, Otsubo T, Nakashima K, Yoshioka G, Yokoi K, Tsuruta K, Osako R, Shichida S, Nishimura Y, Edayoshi M, Kawano Y, Shintani-Domoto Y, Miyazaki K, Fukui A, Kawaguchi A, Aoki S, Nomura S, Takahashi N, Ito K, Node K. Atrial amyloidosis identified by biopsy in atrial fibrillation: prevalence and clinical presentation. Eur Heart J. 2025 doi: 10.1093/eurheartj/ehaf332.
  • Fukui A, Hirota K, Mitarai K, Kondo H, Yamaguchi T, Shinohara T, Takahashi N. Efficacy and limitation of nonparoxysmal atrial fibrillation ablation in patients with heart failure with preserved ejection fraction. J Cardiovasc Electrophysiol. 2025;36:24-31. doi: 10.1111/jce.16463.
  • Yamaguchi T. Atrial structural remodeling and atrial fibrillation substrate: A histopathological perspective. J Cardiol. 2025;85:47-55. doi: 10.1016/j.jjcc.2024.05.007.
  • Huang YS, Pak HN, Hiroshima K, Yamaguchi T, Chen YL, Fukaya H, Soejima K, Yan BP, Morishima I, Shizuta S, Okubo K, Zheng Q, Choi JI, Jiang C, Ieda M, Horvath EE, Lo LW. High-density mapping in catheter ablation for atrial fibrillation in Asia Pacific region: An observational study. J Arrhythm. 2024;41:e13168. doi: 10.1002/joa3.13168.
  • Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera JA, Chugh SS, de Groot JR, Soulat-Dufour L, Fenelon G, Hatem SN, Jalife J, Lin YJ, Lip GYH, Marcus GM, Murray KT, Pak HN, Schotten U, Takahashi N, Yamaguchi T, Zoghbi WA, Nattel S, Mont L, Akar JG, Akoum N, Althoff T, Diaz JC, Guichard JB, Jadidi A, Kalman J, Lim H, Teixeira RA. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. 2024;26:euae204. doi: 10.1093/europace/euae204.
  • Yoshioka G, Yamaguchi T, Tanaka A, Sakai H, Koyamatsu J, Umeki T, Kaneta K, Sakamoto Y, Kawaguchi A, Node K. Impact of left atrial strain on clinical outcomes in patients with permanent pacemaker implantation. ESC Heart Fail. 2024;11:3982-3992. doi: 10.1002/ehf2.14973.
  • Yokoi K, Katsuki T, Yamaguchi T*, Otsubo T, Soga Y, Hiroshima K, Sonoda S, Node K. Pulmonary Vein Intervention for Severe Pulmonary Vein Stenosis After Atrial Fibrillation Ablation - A Retrospective Cohort Study. Circ J. 2024;88:1099-1106. doi: 10.1253/circj.CJ-23-0892.
  • Nishimura Y, Takahashi Y, Yokoi K, Yamaguchi T, Node K. Transcatheter Biopsy of Primary Cardiac Tumors Guided by Echocardiographic and Fluoroscopic Imaging. Circ J. 2023;88:175. doi: 10.1253/circj.CJ-23-0819.
  • Yamaguchi T. Atrial Fibrillation Ablation and the ABC-Death Score: Beyond Rhythm Outcomes. JACC Asia. 2023;3:802-804. doi: 10.1016/j.jacasi.2023.08.005.
  • Takahashi Y, Yamaguchi T, Otsubo T, Nakashima K, Shinzato K, Osako R, Shichida S, Kawano Y, Fukui A, Kawaguchi A, Aishima S, Saito T, Takahashi N, Node K. Histological validation of atrial structural remodelling in patients with atrial fibrillation. Eur Heart J. 2023;44:3339-3353. doi: 10.1093/eurheartj/ehad396.
  • Hirota K, Fukui A, Yamaguchi T, Takahashi M, Kondo H, Akioka H, Shinohara T, Yufu K, Node K, Takahashi N. Interatrial conduction time is associated with left atrial low voltage area and predicts the recurrence after single atrial fibrillation ablation. J Arrhythm. 2023 Jan 23;39(2):142-148. doi: 10.1002/joa3.12820.
  • Sagawa Y, Nagata Y, Miwa N, Yamaguchi T, Watanabe K, Kaneko M, Nakamura T, Nozato T, Ashikaga T, Goya M, Sasano T. Alcohol Consumption Is Associated With Postablation Recurrence but Not Changes in Atrial Substrate in Patients With Atrial Fibrillation: Insight from a High-Density Mapping Study. J Am Heart Assoc. 2022;11:e025697. doi: 10.1161/JAHA.121.025697.
  • Yamaguchi T, Otsubo T, Takahashi Y, Nakashima K, Fukui A, Hirota K, Ishii Y, Shinzato K, Osako R, Tahara M, Kawano Y, Kawaguchi A, Aishima S, Takahashi N, Node K. Atrial Structural Remodeling in Patients With Atrial Fibrillation Is a Diffuse Fibrotic Process: Evidence From High-Density Voltage Mapping and Atrial Biopsy. J Am Heart Assoc. 2022;11:e024521. doi: 10.1161/JAHA.121.024521.
  • Takahashi Y, Yamaguchi T, Fukui A, Otsubo T, Hirota K, Kawano Y, Nakashima K, Tahara M, Kitai T, Kawaguchi A, Takahashi N, Node K. Impact of Renal Dysfunction on Left Atrial Structural Remodeling and Recurrence After Catheter Ablation for Atrial Fibrillation - A Propensity Score Matching Analysis. Circ J. 2020;84:1254-1260. doi: 10.1253/circj.CJ-20-0149.
  • Fukui A, Tanino T, Yamaguchi T, Hirota K, Saito S, Okada N, Akioka H, Shinohara T, Yufu K, Takahashi N. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction. J Cardiovasc Electrophysiol. 2020;31:682-688. doi: 10.1111/jce.14369.
  • Csécs I, Yamaguchi T, Kheirkhahan M, Czimbalmos C, Fochler F, Kholmovski EG, Morris AK, Kaur G, Vago H, Merkely B, Chelu MG, Marrouche NF, Wilson BD. Left atrial functional and structural changes associated with ablation of atrial fibrillation – Cardiac magnetic resonance study. Int J Cardiol. 2020;305:154-160. doi: 10.1016/j.ijcard.2019.12.010.
  • Huang C, Wasmund SL, Yamaguchi T, Knighton N, Hitchcock RW, Polejaeva IA, White KL, Marrouche NF, Sachse FB. Towards Automated Quantification of Atrial Fibrosis in Images from Catheterized Fiber-Optics Confocal Microscopy Using Convolutional Neural Networks. Funct Imaging Model Heart. 2019;11504:168-176. doi: 10.1007/978-3-030-21949-9_19.
  • Fochler F, Yamaguchi T, Kheirkahan M, Kholmovski EG, Morris AK, Marrouche NF. Late Gadolinium Enhancement Magnetic Resonance Imaging Guided Treatment of Post-Atrial Fibrillation Ablation Recurrent Arrhythmia. Circ Arrhythm Electrophysiol. 2019;12:e007174. doi: 10.1161/CIRCEP.119.007174.
  • Yamaguchi T, Fukui A, Node K. Bipolar Voltage Mapping for the Evaluation of Atrial Substrate: Can We Overcome the Challenge of Directionality? J Atr Fibrillation. 2019 ;11:2116. doi: 10.4022/jafib.2116.
  • Yamaguchi T, Marrouche NF. Consider temporal aggressive rhythm control before ICD implantation in patients with heart failure with reduced ejection fraction. Europace. 2019;21:835-837. doi: 10.1093/europace/euz052.
  • Otsubo T, Tsuchiya T, Yamaguchi T, Takahashi N. Left atrial low-voltage zone ablation of persistent atrial fibrillation in a patient with myotonic dystrophy: A case report. J Arrhythm. 2018;34:302-304. doi: 10.1002/joa3.12059.
  • Yamaguchi T, Tsuchiya T, Fukui A, Kawano Y, Otsubo T, Takahashi Y, Hirota K, Murotani K, Eshima K, Takahashi N. Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation. J Cardiol. 2018;72:427-433. doi: 10.1016/j.jjcc.2018.04.010.
  • Yamaguchi T, Marrouche NF. Recurrence Post-Atrial Fibrillation Ablation: Think Outside the Pulmonary Veins. Circ Arrhythm Electrophysiol. 2018;11:e006379. doi: 10.1161/CIRCEP.118.006379.
  • Yamaguchi T, Shimakawa Y, Mitsumizo S, Fukui A, Kawano Y, Otsubo T, Takahashi Y, Hirota K, Tsuchiya T, Eshima K. Feasibility of total intravenous anesthesia by cardiologists with the support of anesthesiologists during catheter ablation of atrial fibrillation. J Cardiol. 2018;72:19-25. doi: 10.1016/j.jjcc.2017.12.008.